INNOVATIVE EYEWEAR INC (LUCY) Fundamental Analysis & Valuation
NASDAQ:LUCY • US45791D2080
Current stock price
1.1 USD
+0.02 (+1.85%)
Last:
This LUCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LUCY Profitability Analysis
1.1 Basic Checks
- In the past year LUCY has reported negative net income.
- In the past year LUCY has reported a negative cash flow from operations.
- LUCY had negative earnings in each of the past 5 years.
- In the past 5 years LUCY always reported negative operating cash flow.
1.2 Ratios
- LUCY's Return On Assets of -70.22% is on the low side compared to the rest of the industry. LUCY is outperformed by 75.53% of its industry peers.
- Looking at the Return On Equity, with a value of -76.56%, LUCY is in line with its industry, outperforming 40.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -76.56% | ||
| ROIC | N/A |
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- LUCY's Gross Margin of 22.83% is on the low side compared to the rest of the industry. LUCY is outperformed by 79.26% of its industry peers.
- LUCY's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for LUCY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
2. LUCY Health Analysis
2.1 Basic Checks
- LUCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
- There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -0.48, we must say that LUCY is in the distress zone and has some risk of bankruptcy.
- LUCY has a Altman-Z score of -0.48. This is comparable to the rest of the industry: LUCY outperforms 42.02% of its industry peers.
- There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.48 |
ROIC/WACCN/A
WACC8.95%
2.3 Liquidity
- A Current Ratio of 11.98 indicates that LUCY has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 11.98, LUCY belongs to the top of the industry, outperforming 96.81% of the companies in the same industry.
- A Quick Ratio of 10.13 indicates that LUCY has no problem at all paying its short term obligations.
- LUCY's Quick ratio of 10.13 is amongst the best of the industry. LUCY outperforms 96.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 11.98 | ||
| Quick Ratio | 10.13 |
3. LUCY Growth Analysis
3.1 Past
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%38.99%
3.2 Future
- Based on estimates for the next years, LUCY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.61% on average per year.
- The Revenue is expected to grow by 175.43% on average over the next years. This is a very strong growth
EPS Next Y22.16%
EPS Next 2Y32.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year148.28%
Revenue Next 2Y175.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
4. LUCY Valuation Analysis
4.1 Price/Earnings Ratio
- LUCY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LUCY. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as LUCY's earnings are expected to grow with 32.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.61%
EPS Next 3YN/A
5. LUCY Dividend Analysis
5.1 Amount
- No dividends for LUCY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LUCY Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:LUCY (4/13/2026, 8:00:01 PM)
1.1
+0.02 (+1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25 2026-03-25/amc
Earnings (Next)N/A N/A
Inst Owners6.22%
Inst Owner Change0%
Ins Owners7.67%
Ins Owner Change-16.59%
Market Cap6.93M
Revenue(TTM)N/A
Net Income(TTM)-7.85M
Analysts82.86
Price Target3.06 (178.18%)
Short Float %1.7%
Short Ratio0.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.97%
Min EPS beat(2)15.97%
Max EPS beat(2)23.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.87%
Min Revenue beat(2)-43.24%
Max Revenue beat(2)-34.5%
Revenue beat(4)0
Avg Revenue beat(4)-41.35%
Min Revenue beat(4)-55.39%
Max Revenue beat(4)-32.28%
Revenue beat(8)1
Avg Revenue beat(8)-18.57%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.9 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.68 | ||
| P/tB | 0.71 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.9
EYN/A
EPS(NY)-1.48
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS0.38
BVpS1.63
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -76.56% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.83% | ||
| FCFM | N/A |
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 89.89% | ||
| Cap/Sales | 5.5% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 11.98 | ||
| Quick Ratio | 10.13 | ||
| Altman-Z | -0.48 |
F-Score3
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)402.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.82%
Cap/Sales(5y)37.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y22.16%
EPS Next 2Y32.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%38.99%
Revenue Next Year148.28%
Revenue Next 2Y175.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.33%
EBIT Next 3Y15.27%
EBIT Next 5YN/A
FCF growth 1Y-29.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.43%
OCF growth 3YN/A
OCF growth 5YN/A
INNOVATIVE EYEWEAR INC / LUCY Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for INNOVATIVE EYEWEAR INC?
ChartMill assigns a fundamental rating of 3 / 10 to LUCY.
What is the valuation status of INNOVATIVE EYEWEAR INC (LUCY) stock?
ChartMill assigns a valuation rating of 1 / 10 to INNOVATIVE EYEWEAR INC (LUCY). This can be considered as Overvalued.
How profitable is INNOVATIVE EYEWEAR INC (LUCY) stock?
INNOVATIVE EYEWEAR INC (LUCY) has a profitability rating of 0 / 10.
What is the financial health of INNOVATIVE EYEWEAR INC (LUCY) stock?
The financial health rating of INNOVATIVE EYEWEAR INC (LUCY) is 7 / 10.